291 related articles for article (PubMed ID: 30816813)
1. Use of Medicare Administrative Claims to Identify a Population at High Risk for Adverse Drug Events and Hospital Use for Quality Improvement.
Digmann R; Thomas A; Peppercorn S; Ryan A; Zhang L; Irby K; Brock J
J Manag Care Spec Pharm; 2019 Mar; 25(3):402-410. PubMed ID: 30816813
[TBL] [Abstract][Full Text] [Related]
2. E-Prescribing and Adverse Drug Events: An Observational Study of the Medicare Part D Population With Diabetes.
Gabriel MH; Powers C; Encinosa W; Bynum JP
Med Care; 2017 May; 55(5):456-462. PubMed ID: 28060051
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among Medicare beneficiaries.
Shehab N; Ziemba R; Campbell KN; Geller AI; Moro RN; Gage BF; Budnitz DS; Yang TH
Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):951-964. PubMed ID: 31144403
[TBL] [Abstract][Full Text] [Related]
4. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014.
Shehab N; Lovegrove MC; Geller AI; Rose KO; Weidle NJ; Budnitz DS
JAMA; 2016 Nov; 316(20):2115-2125. PubMed ID: 27893129
[TBL] [Abstract][Full Text] [Related]
5. Identification of Emergency Department Visits in Medicare Administrative Claims: Approaches and Implications.
Venkatesh AK; Mei H; Kocher KE; Granovsky M; Obermeyer Z; Spatz ES; Rothenberg C; Krumholz HM; Lin Z
Acad Emerg Med; 2017 Apr; 24(4):422-431. PubMed ID: 27864915
[TBL] [Abstract][Full Text] [Related]
6. Incorporating Present-on-Admission Indicators in Medicare Claims to Inform Hospital Quality Measure Risk Adjustment Models.
Triche EW; Xin X; Stackland S; Purvis D; Harris A; Yu H; Grady JN; Li SX; Bernheim SM; Krumholz HM; Poyer J; Dorsey K
JAMA Netw Open; 2021 May; 4(5):e218512. PubMed ID: 33978722
[TBL] [Abstract][Full Text] [Related]
7. Development of claims-based measures of unplanned acute care with superior power for assessing the effectiveness of interventions following acute care.
Chen AY; Blue L; Tilipman J; McCall N
Health Serv Res; 2021 Jun; 56(3):550-557. PubMed ID: 33543477
[TBL] [Abstract][Full Text] [Related]
8. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
9. Evaluating whether changes in utilization of hospital outpatient services contributed to lower Medicare readmission rate.
Gerhardt G; Yemane A; Apostle K; Oelschlaeger A; Rollins E; Brennan N
Medicare Medicaid Res Rev; 2014; 4(1):. PubMed ID: 25009762
[TBL] [Abstract][Full Text] [Related]
10. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
Leslie RS; Tirado B; Patel BV; Rein PJ
J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
[TBL] [Abstract][Full Text] [Related]
12. Use of ICD-10-CM T codes in hospital claims data to identify adverse drug events in Taiwan.
Cheng YF; Cheng CY; Wang SH; Lin YT; Tsai TC
J Clin Pharm Ther; 2021 Apr; 46(2):476-483. PubMed ID: 33210301
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance.
Classen DC; Jaser L; Budnitz DS
Jt Comm J Qual Patient Saf; 2010 Jan; 36(1):12-21. PubMed ID: 20112660
[TBL] [Abstract][Full Text] [Related]
14. Variation in Facility-Level Rates of All-Cause and Potentially Preventable 30-Day Hospital Readmissions Among Medicare Fee-for-Service Beneficiaries After Discharge From Postacute Inpatient Rehabilitation.
Malcolm MP; Middleton A; Haas A; Ottenbacher KJ; Graham JE
JAMA Netw Open; 2019 Dec; 2(12):e1917559. PubMed ID: 31834398
[TBL] [Abstract][Full Text] [Related]
15. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for opioid-related adverse drug events among older adults after hospital discharge.
Herzig SJ; Anderson TS; Jung Y; Ngo LH; McCarthy EP
J Am Geriatr Soc; 2022 Jan; 70(1):228-234. PubMed ID: 34528242
[TBL] [Abstract][Full Text] [Related]
17. Association between quality improvement for care transitions in communities and rehospitalizations among Medicare beneficiaries.
Brock J; Mitchell J; Irby K; Stevens B; Archibald T; Goroski A; Lynn J;
JAMA; 2013 Jan; 309(4):381-91. PubMed ID: 23340640
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.
Almodóvar AS; Nahata MC
J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057
[TBL] [Abstract][Full Text] [Related]
20. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
